Todos os posts

Estudo de coorte baseado em registro | Fatores de risco modificáveis e não modificáveis na mortalidade da fratura de quadril na Noruega, 2014 a 2018.

18 Jul, 2022 | 13:17h

Modifiable and non-modifiable risk factors in hip fracture mortality in Norway, 2014 to 2018 – The Bone & Joint Journal

 

---

Estudo randomizado fase 2 | Eficácia de mFOLFIRINOX pré-operatório vs. mFOLFIRINOX com radioterapia hipofracionada para adenocarcinoma ressecável limítrofe do pâncreas.

18 Jul, 2022 | 13:16h

Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the PancreasThe A021501 Phase 2 Randomized Clinical Trial – JAMA Oncology (gratuito por tempo limitado)

Editorial: The Continued Struggle for Defining a Role for Radiotherapy in Pancreas Cancer – JAMA (gratuito por tempo limitado)

Comunicado de imprensa: Preoperative combination chemotherapy improved survival in patients with pancreatic cancer – The University of Texas MD Anderson Cancer Center

 

Comentário no Twitter

Ph 2 trial of 126 pts w/borderline resectable pancreatic ductal adenoCa shows 18 mo OS after neoadjuvant mFOLFIRINOX of 66.7%, favorable vs. historical data; 18m OS if mFOLFORINOX then hypofract RT is 47.3%, if chemo then pancreatectomy is 87.5%. https://t.co/wOMNrTOAzm

— JAMA Oncology (@JAMAOnc) July 14, 2022

 

---

Eficácia e segurança de 1 ano do creme Tapinarof para tratamento da psoríase em placas.

18 Jul, 2022 | 13:15h

One-Year Safety and Efficacy of Tapinarof Cream for the Treatment of Plaque Psoriasis: Results from the PSOARING 3 Trial – Journal of the American Academy of Dermatology

Comunicado de imprensa: Tapinarof Effective for Longer-Term Treatment of Plaque Psoriasis – HealthDay

Estudo relacionado: Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis – New England Journal of Medicine

 

---

Estudo randomizado | Deucravacitinibe vs. placebo vs. apremilaste na psoríase em placas moderada a grave.

18 Jul, 2022 | 13:14h

Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial – Journal of the American Academy of Dermatology (link para o resumo – $ para o texto completo)

 

---

Pseudo-obstrução intestinal pediátrica: progresso e desafios.

18 Jul, 2022 | 13:12h

Pediatric Intestinal Pseudo-Obstruction: Progress and Challenges – Frontiers in Pediatrics

 

---

Revisão | Strongyloides stercoralis.

18 Jul, 2022 | 13:11h

Strongyloides stercoralis – Lung (se o acesso a este link for pago, tente este)

 

---

Revisão sistemática de escopo | Estudos randomizados na saúde materna e perinatal em países de baixa e média rendas de 2010 a 2019.

18 Jul, 2022 | 13:09h

Randomised trials in maternal and perinatal health in low and middle-income countries from 2010 to 2019: a systematic scoping review – BMJ Open

 

---

Estudo de coorte | Comparação de critérios diagnósticos na lesão renal aguda em pacientes pediátricos críticos.

18 Jul, 2022 | 13:08h

Comparison of diagnostic criteria for acute kidney injury in critically ill children: a multicenter cohort study – Critical Care

 

---

M-A | Vortioxetina para tratamento de transtorno depressivo maior em adultos.

18 Jul, 2022 | 13:07h

Systematic Review and Meta-Analysis of Vortioxetine for the Treatment of Major Depressive Disorder in Adults – Frontiers in Psychiatry

 

---

Evidências e fontes da Cochrane Library | Úlceras de pressão.

18 Jul, 2022 | 13:05h

Pressure ulcers (pressure injuries): evidence and resources – Evidently Cochrane

 

---